← Back to Screener
Kestra Medical Technologies, Ltd. Common Stock (KMTS)
Price$23.31
Favorite Metrics
Price vs S&P 500 (26W)-5.07%
Price vs S&P 500 (4W)9.93%
Market Capitalization$1.33B
All Metrics
Book Value / Share (Quarterly)$4.94
Indicated Dividend (Annual)$0.00
Cash Flow / Share (Quarterly)$-2.04
Price vs S&P 500 (YTD)-18.13%
Gross Margin (TTM)48.75%
Net Profit Margin (TTM)-172.99%
EPS (TTM)$-2.80
10-Day Avg Trading Volume0.26M
EPS Excl Extra (TTM)$-2.80
EPS (Annual)$-2.30
ROI (Annual)-46.17%
Gross Margin (Annual)40.47%
Cash / Share (Quarterly)$4.99
Revenue Growth QoQ (YoY)62.70%
ROA (Last FY)-38.48%
Revenue Growth TTM (YoY)59.06%
EBITD / Share (TTM)$-2.61
Operating Margin (TTM)-171.53%
Cash Flow / Share (Annual)$-2.03
P/B Ratio4.62x
P/B Ratio (Quarterly)5.07x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)12.93x
Net Interest Coverage (TTM)-24.07x
ROA (TTM)-48.76%
EPS Incl Extra (Annual)$-2.30
Current Ratio (Annual)6.72x
Quick Ratio (Quarterly)7.28x
3-Month Avg Trading Volume0.34M
52-Week Price Return-7.20%
Revenue / Employee (TTM)$0
P/S Ratio (Annual)22.26x
Asset Turnover (Annual)0.20x
52-Week High$30.00
EPS Excl Extra (Annual)$-2.30
26-Week Price Return3.68%
Quick Ratio (Annual)6.69x
13-Week Price Return2.20%
Total Debt / Equity (Annual)0.20x
Current Ratio (Quarterly)7.32x
Enterprise Value$1,082.436
Asset Turnover (TTM)0.28x
Revenue / Employee (Annual)$0
Pretax Margin (Annual)-190.05%
Cash / Share (Annual)$4.80
3-Month Return Std Dev64.91%
Net Income / Employee (TTM)$-0
ROE (Last FY)-55.41%
Net Interest Coverage (Annual)-76.35x
EPS Basic Excl Extra (Annual)$-2.30
Receivables Turnover (TTM)8.11x
Total Debt / Equity (Quarterly)0.15x
EPS Incl Extra (TTM)$-2.80
ROI (TTM)-57.45%
P/S Ratio (TTM)15.90x
Revenue / Share (Annual)$1.21
Price vs S&P 500 (52W)-42.30%
Year-to-Date Return-13.99%
5-Day Price Return21.59%
EPS Normalized (Annual)$-2.30
Net Profit Margin (Annual)-190.28%
Month-to-Date Return14.45%
EBITD / Share (Annual)$-2.04
Operating Margin (Annual)-177.85%
LT Debt / Equity (Annual)0.20x
LT Debt / Equity (Quarterly)0.15x
EPS Basic Excl Extra (TTM)$-2.80
P/B Ratio (Annual)6.01x
Pretax Margin (TTM)-171.62%
Book Value / Share (Annual)$4.15
Price vs S&P 500 (13W)-0.67%
Beta1.96x
Revenue / Share (TTM)$1.50
ROE (TTM)-68.83%
52-Week Low$13.25
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.31
4.31
4.31
4.31
Industry Peers — Surgical & Medical Instruments(108)
| Symbol | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
KMTSKestra Medical Technologies, Ltd. Common Stock | 15.90x | — | 48.75% | -171.53% | $23.31 |
SYKStryker Corporation | 5.17x | 11.84% | 64.57% | 19.43% | $338.34 |
BSXBoston Scientific Corp. | 4.58x | 15.16% | 69.01% | 18.00% | $60.99 |
MMM3M Company | 3.21x | -4.97% | 39.92% | 18.55% | $151.40 |
MDLNMedline Inc. Class A common stock | 2.20x | — | 26.44% | 7.78% | $48.26 |
BDXBecton, Dickinson and Co. | 2.06x | 6.32% | 46.42% | 12.15% | $158.64 |
RMDResMed Inc. | 6.07x | 11.72% | 60.85% | 33.70% | $226.14 |
DXCMDexCom, Inc. | 5.33x | 19.33% | 62.09% | 19.56% | $64.62 |
WSTWest Pharmaceutical Services, Inc. | 6.29x | 7.44% | 35.91% | 19.03% | $278.00 |
PODDInsulet Corporation | 5.19x | 24.53% | 71.63% | 12.92% | $200.87 |
PENPenumbra, Inc. | 9.24x | 20.16% | 67.14% | 13.48% | $329.71 |
About
Kestra Medical Technologies is a commercial-stage company developing wearable medical devices and digital healthcare solutions for cardiovascular disease management. Its Cardiac Recovery System platform integrates monitoring, therapy, digital health, and patient support into a unified solution centered on the ASSURE WCD, a wearable cardioverter defibrillator designed to prevent sudden cardiac arrest in high-risk patients. The company targets a significant clinical need by combining advanced wearable technology with connected digital services for cardiac care.